Russell Investments Group Ltd. Sells 22,366 Shares of Select Medical Holdings Co. (NYSE:SEM)

Russell Investments Group Ltd. lowered its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 40.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 32,988 shares of the health services provider’s stock after selling 22,366 shares during the period. Russell Investments Group Ltd.’s holdings in Select Medical were worth $853,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its holdings in Select Medical by 6.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,617,462 shares of the health services provider’s stock worth $511,932,000 after acquiring an additional 1,170,674 shares during the last quarter. BlackRock Inc. lifted its position in shares of Select Medical by 4.3% in the 1st quarter. BlackRock Inc. now owns 18,575,139 shares of the health services provider’s stock worth $445,617,000 after purchasing an additional 762,219 shares during the period. Vanguard Group Inc. lifted its position in shares of Select Medical by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 12,859,730 shares of the health services provider’s stock worth $308,505,000 after purchasing an additional 72,327 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in shares of Select Medical by 3.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,609,861 shares of the health services provider’s stock worth $164,123,000 after purchasing an additional 230,889 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Select Medical by 1.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,708,986 shares of the health services provider’s stock worth $116,924,000 after purchasing an additional 70,058 shares during the period. Institutional investors own 76.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on SEM. StockNews.com started coverage on shares of Select Medical in a research report on Thursday, August 17th. They issued a “buy” rating for the company. Credit Suisse Group lifted their price target on shares of Select Medical from $29.00 to $32.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Royal Bank of Canada reissued an “outperform” rating and set a $38.00 price target on shares of Select Medical in a research report on Thursday, July 20th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Select Medical from $35.00 to $37.00 in a research report on Monday, May 8th. Finally, TheStreet upgraded shares of Select Medical from a “c+” rating to a “b” rating in a research note on Wednesday, May 17th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Select Medical presently has an average rating of “Moderate Buy” and a consensus target price of $36.50.

Select Medical Stock Performance

Shares of SEM stock opened at $29.03 on Friday. The company has a 50 day moving average price of $29.90 and a 200-day moving average price of $28.57. Select Medical Holdings Co. has a 52 week low of $18.86 and a 52 week high of $33.51. The firm has a market capitalization of $3.69 billion, a PE ratio of 18.14, a P/E/G ratio of 0.64 and a beta of 1.39. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 2.46.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.61 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.61. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.65 billion. Select Medical had a net margin of 3.14% and a return on equity of 14.52%. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.43 earnings per share. As a group, equities research analysts expect that Select Medical Holdings Co. will post 1.95 earnings per share for the current year.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 1st. Investors of record on Tuesday, August 15th were given a dividend of $0.125 per share. The ex-dividend date was Monday, August 14th. This represents a $0.50 annualized dividend and a yield of 1.72%. Select Medical’s dividend payout ratio (DPR) is 31.25%.

Insider Buying and Selling at Select Medical

In other Select Medical news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction that occurred on Thursday, June 8th. The shares were sold at an average price of $28.63, for a total transaction of $1,431,500.00. Following the transaction, the chairman now owns 6,939,668 shares of the company’s stock, valued at $198,682,694.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Chairman Robert A. Ortenzio sold 100,000 shares of the business’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $32.00, for a total value of $3,200,000.00. Following the transaction, the chairman now owns 1,279,000 shares of the company’s stock, valued at $40,928,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Robert A. Ortenzio sold 50,000 shares of the business’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $28.63, for a total transaction of $1,431,500.00. Following the completion of the transaction, the chairman now directly owns 6,939,668 shares in the company, valued at approximately $198,682,694.84. The disclosure for this sale can be found here. Insiders have sold 283,967 shares of company stock valued at $8,644,510 over the last 90 days. 19.14% of the stock is currently owned by corporate insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: The Critical Illness Recovery Hospital, The Rehabilitation Hospital, The Outpatient Rehabilitation, and The Concentra.